Mechanism of Darunavir (DRV)’s High Genetic Barrier to HIV-1 Resistance: A Key V32I Substitution in Protease Rarely Occurs, but Once It Occurs, It Predisposes HIV-1 To Develop DRV Resistance
Darunavir concentrations in CSF of HIV-infected individuals when boosted with cobicistat versus ritonavir
Tags: AIDS, antiretroviral, HIV, Prezista®
BASi Method Number SAP.1032
Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.
